Who owns HIMS
426 institutions reported holding HIMS for 2026Q1, together 65% of the company, fewer than the 479 a quarter earlier.
426
Institutions reporting a position · as of 2026Q1 · down from 479 the quarter before
- Shares held by institutions
- 148.9M
Shares held by institutions · 65% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $3.09B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 31%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 21
- New positions
- 77
- Positions exited
- 133
- Added to
- 146
- Reduced
- 131
- Top 10 holdersof the company
- 41%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 426 | 148.9M | $3.09B |
| 2025Q4 | 479 | 183.2M | $5.96B |
| 2025Q3 | 506 | 199.7M | $11.3B |
| 2025Q2 | 499 | 175.1M | $8.73B |
| 2025Q1 | 425 | 159.4M | $4.72B |
| 2024Q4 | 391 | 164.2M | $3.97B |
| 2024Q3 | 307 | 137.7M | $2.54B |
| 2024Q2 | 297 | 136.0M | $2.75B |
| 2024Q1 | 243 | 127.6M | $1.97B |
| 2023Q4 | 195 | 124.8M | $1.11B |
| 2023Q3 | 191 | 119.0M | $749M |
| 2023Q2 | 190 | 132.5M | $1.25B |
| 2023Q1 | 188 | 119.6M | $1.18B |
| 2022Q4 | 155 | 105.6M | $679M |
| 2022Q3 | 152 | 94.7M | $529M |
| 2022Q2 | 137 | 88.8M | $403M |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Inc. | 26.3M | 12% | $547M |
| VANGUARD GROUP INC | 21.3M | 9.3% | $442M |
| MORGAN STANLEY | 8.9M | 3.9% | $185M |
| STATE STREET CORP | 7.5M | 3.3% | $155M |
| Defiance ETFs, LLC | 7.4M | 3.3% | $154M |
| JPMORGAN CHASE & CO | 5.2M | 2.3% | $98M |
| GEODE CAPITAL MANAGEMENT LLC | 5.2M | 2.3% | $108M |
| BANK OF AMERICA CORP /DE/ | 4.4M | 1.9% | $90M |
| UBS Group AG | 4.2M | 1.8% | $86M |
| GOLDMAN SACHS GROUP INC | 2.5M | 1.1% | $51M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #16 of 28 by Smart Score